EUVIMEDEUVIMED entdecken
Crossref

Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay

Ulrike Wehkamp, Sophie Pietzka, Michaela Kotrová, Marion Jost, Ilske Oschlies, Agatha Schwarz, Claudia Baldus, Nikos Darzentas, Monika Brüggemann

British Journal of Dermatology · 2025

DOI: 10.1093/bjd/ljae425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Ulrike Wehkamp und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms, Neoplastic Cells, Circulating, Dermatitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Christian-Albrechts University of Kiel, Christian–Albrechts University of Kiel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycosis fungoides (MF) is a rare malignancy that is characterized by the presence of circulating tumour cells (CTCs) in a subgroup of patients. Reliably distinguishing MF from inflammatory skin conditions is challenging.

Objectives

To evaluate the potential benefits of next-generation sequencing (NGS)-based T-cell receptor rearrangement repertoire analysis in detecting clonal rearrangements in MF and inflammatory skin conditions.

Methods

Skin biopsies and blood samples from 33 patients with MF and 10 patients with inflammatory skin conditions were analysed using TRB and TRG NGS. Twenty-seven patients had early-stage IA (n = 19) and IB (n = 8) MF, and six had advanced-stage disease (IIB, n = 5; IIIA, n = 1).

Results

Analysis applying standard abundance thresholds identified at least one clonal rearrangement in the skin DNA of 97% (n = 32/33) of patients with MF and in 90% (n = 9/10) of those with inflammatory skin conditions. To enhance specificity, an abundance and distribution-based approach was applied, which considered only rearrangements that significantly stood out from the physiological background as clonal (MF, n = 29/33; inflammatory skin conditions, n = 1/10), allowing for highly sensitive (88%) and specific (90%) discrimination between MF and other inflammatory skin conditions. CTCs were detected in 46% (n = 11/24) of patients with early-stage MF and in 60% (n = 3/5) of those with late-stage MF.

Conclusions

NGS-based T-cell receptor repertoire analysis is a highly sensitive and specific method for the differential diagnosis of early-stage MF vs. inflammatory skin conditions, and for the sensitive molecular detection of CTCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycosis FungoidesSkin NeoplasmsNeoplastic Cells, CirculatingDermatitisHumansHigh-Throughput Nucleotide SequencingMaleFemaleMiddle AgedAgedAdultDiagnosis, DifferentialAged, 80 and overYoung AdultGene Rearrangement, T-LymphocyteReceptors, Antigen, T-Cell

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Medical School Hamburg, Hamburg, Germany.
  • Department of Hematology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Förderung

  • Christian-Albrechts University of Kiel
  • Christian–Albrechts University of Kiel

Zitieren

APA

Wehkamp, U., Pietzka, S., Kotrová, M., Jost, M., Oschlies, I., Schwarz, A., Baldus, C., Darzentas, N., & Brüggemann, M. (2025). Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae425

Vancouver

Wehkamp U, Pietzka S, Kotrová M, Jost M, Oschlies I, Schwarz A, et al. Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljae425

BibTeX
@article{Wehkamp2025,
  author = {Wehkamp, Ulrike and Pietzka, Sophie and Kotrová, Michaela and Jost, Marion and Oschlies, Ilske and Schwarz, Agatha and Baldus, Claudia and Darzentas, Nikos and Brüggemann, Monika},
  title = {Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay},
  journal = {British Journal of Dermatology},
  year = {2025},
  doi = {10.1093/bjd/ljae425}
}
Kostenlos starten →